Author

J. C. Chavez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1 Approach:wet-lab / biochemical assay· 1

Frequent Co-Authors

A. Quinones-Hinojosa· 1 shared B. Zhao· 1 shared Hong Qin· 1 shared J. W. Jakub· 1 shared L. P. Deleyrolle· 1 shared M. A. Kharfan-Dabaja· 1 shared M. Brooks· 1 shared M. J. Ulloa-Navas· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

A. Quinones-Hinojosa

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A Standalone PD-1 Chimeric Switch Receptor T-Cell Platform Expands the Therapeutic Window of PD-L1 Targeting in Solid Tumors

Y. Luo, S. Guo, Y. Qie, B. Zhao, M. J. Ulloa-Navas, M. Brooks, V. Jones, T. Hundal, J. C. Chavez, Y. Lou, L. P. Deleyrolle, V. Velcheti, J. W. Jakub, R. Dronca, M. A. Kharfan-Dabaja, , Hong Qin

This paper develops a PD-1 chimeric switch receptor T-cell platform that improves tumor targeting while reducing toxicity to normal cells in PD-L1-targeted therapies.

bioRxiv · Nov 9, 2026 · PreprintMolecular Biology